The company
Boundless Bio, Inc.
BOLD · Nasdaq
BOLD stood above a rising 150-day average in 28 of the last 52 weekly readings, including each of the last 27 weeks. It is 10.7% above that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 27 in a row
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $3.4M
- Insider sales, 12 months
- $268K
- Officials’ trades on record
- 0
- Institutions holding
- 38 (+5)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 28 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Kevin Tang10% owner | bought | 220at $2.37 | 20 Oct 2026filed 20 Oct 2026 |
| Kevin Tang10% owner | bought | 12,790at $2.34 | 19 Oct 2026filed 20 Oct 2026 |
| Kevin Tang10% owner | bought | 18,279at $2.33 | 19 Oct 2026filed 20 Oct 2026 |
| Kevin Tang10% owner | bought | 118,185at $2.34 | 16 Oct 2026filed 20 Oct 2026 |
| Kevin Tang10% owner | sold | 18,300at $2.97 | 26 Aug 2026filed 28 Aug 2026 |
| Kevin Tang10% owner | bought | 2,975at $2.44 | 21 Jul 2026filed 21 Jul 2026 |
| Kevin Tang10% owner | bought | 1,623at $2.44 | 20 Jul 2026filed 21 Jul 2026 |
| Kevin Tang10% owner | bought | 265at $2.44 | 17 Jul 2026filed 21 Jul 2026 |
| Kevin Tang10% owner | bought | 18,491at $2.44 | 16 Jul 2026filed 16 Jul 2026 |
| Kevin Tang10% owner | bought | 1,600at $2.44 | 15 Jul 2026filed 16 Jul 2026 |
| Kevin Tang10% owner | bought | 43,878at $2.43 | 14 Jul 2026filed 16 Jul 2026 |
| Kevin Tang10% owner | bought | 48,211at $2.42 | 13 Jul 2026filed 13 Jul 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| ARCH Venture Management, LLCnew · filed 14 Aug 2026 | 2,694,095$6.7M | +2,694,095 |
| FMR LLCreduced · filed 13 Aug 2026 | 2,581,055$6.5M | -114,400−4.2% |
| TANG CAPITAL MANAGEMENT LLCnew · filed 14 Aug 2026 | 2,559,875$6.4M | +2,559,875 |
| ADAR1 Capital Management, LLCnew · filed 14 Aug 2026 | 1,968,216$4.9M | +1,968,216 |
| Cormorant Asset Management, LPnew · filed 14 Aug 2026 | 1,000,000$2.5M | +1,000,000 |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 614,923$1.5M | +17,731+3.0% |
| WELLINGTON MANAGEMENT GROUP LLPunchanged · filed 14 Aug 2026 | 556,233$1.4M | 00.0% |
| MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026 | 478,639$1.2M | +378,764+379.2% |
| RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026 | 471,570$1.2M | +72,570+18.2% |
| Alyeska Investment Group, L.P.unchanged · filed 14 Aug 2026 | 300,000$750K | 00.0% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.